BeOne Medicines (NASDAQ:ONC – Get Free Report) issued its quarterly earnings data on Wednesday. BeOne Medicines had a return on equity of 12.06% and a net margin of 8.94%. Here are the key takeaways from BeOne Medicines’ conference call:Get BeOne Medicines alerts:Q2 results exceeded expectations: Revenue reached $1.7 billion, up 30% year over year, while GAAP diluted EPS increased 144% to $2.05. BeOne Medicines Price PerformanceShares of BeOne Medicines stock traded up $6.18 during trading on Wednesday, hitting $329.19. Further ReadingReceive News & Ratings for BeOne Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeOne Medicines and related companies with MarketBeat.com's FREE daily email newsletter.